Elite Pharmaceuticals Inc. (OTCMKTS:ELTP – Get Free Report)’s stock price crossed above its 50-day moving average during trading on Thursday . The stock has a 50-day moving average of $0.36 and traded as high as $0.3999. Elite Pharmaceuticals shares last traded at $0.3850, with a volume of 387,855 shares changing hands.
Elite Pharmaceuticals Stock Up 2.6%
The business has a fifty day moving average price of $0.36 and a two-hundred day moving average price of $0.41. The company has a current ratio of 7.34, a quick ratio of 5.44 and a debt-to-equity ratio of 0.05. The company has a market cap of $425.58 million, a price-to-earnings ratio of 13.17 and a beta of 0.38.
About Elite Pharmaceuticals
Elite Pharmaceuticals, Inc is a U.S.-based specialty pharmaceutical company that acquires, develops and markets both branded and generic pharmaceutical products. Headquartered in Houston, Texas, the company focuses on complex dosage forms—including injectables, sterile formulations and oncology therapies—and seeks to address unmet medical needs through advanced drug delivery technologies. Its product portfolio spans therapeutic areas such as pain management, oncology and cardiovascular care.
Since its founding in 2007, Elite Pharmaceuticals has pursued strategic partnerships and licensing agreements to expand its pipeline and manufacturing capabilities.
Featured Articles
- Five stocks we like better than Elite Pharmaceuticals
- 3 Stocks That Could Benefit as the Robotaxi Race Heats Up
- 3 Waste Stocks Turning AI Investments into Growth
- 3 Overlooked Tech ETFs That Are Quietly Killing It This Year
- 3 ETFs Pairing Market-Beating Returns With High Dividend Yields
Receive News & Ratings for Elite Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Elite Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
